# Bob Kocher

> Bob Kocher is a Series C investor at Stanford University backing Health Care. See 17 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Stanford University](https://shizune.co/investors/profile/stanford-university)
- Location: Palo Alto, United States
- Total investments: 17
- Last investment: Jan 2024
- Lead investor: 35%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/bob-kocher-2177232/
- X (Twitter): http://twitter.com/bobkocher
- Website: https://x.com/bobkocher

Bob Kocher is a Series C investor at Stanford University in Palo Alto focused on Health Care and Wellness. Bob Kocher, MD is a Partner at Venrock and focuses on healthcare IT and services investments. He currently serves on the Boards of Devoted Health, Virta Health, Aledade, Lyra Health, where he is also a co-founder, and Premera. He is a Board Observer at Grand Rounds, Stride, Renew, Doctor on Demand, and Robin. He is formerly a Director at Jiff andCastlight Health (CSLT). Additionally, he is an Adjunct Professor at Stanford University School of Medicine, Senior Fellow and Advisory Board Member at the Leonard D. Schaeffer Center for Health Policy and Economics at USC, and Guest Scholar at the Brookings Institution. He serves on the Advisory Boards of Harvard Medical School Health Care Policy Department and National Institute of Healthcare Management (NIHCM). He is also a member of the Health Affairs Editorial Board.Prior to Venrock, Bob served in the Obama Administration as Special Assistant to the President for Healthcare and Economic Policy on the National Economic Council. In the Obama Administration, Bob was one of the shapers of the Affordable Care Act focusing on cost, quality, and delivery system reform and health IT policy. He was one of the leaders of the First Lady’s “Let’s Move” childhood obesity initiative, led the formation of the Partnership for a Healthier America, and served on the Federal Advisory Panel charged with developing a national obesity strategy. He also co-founded the Health Data Initiative with Todd Park, a joint effort of HHS and the Institute of Medicine, to release healthcare data to spur private sector innovation to improve healthcare cost and quality. For the past five years, he has served as Co-Chair of the Health Datapalooza.Before the White House, Bob was a Partner at McKinsey & Company where he led McKinsey Global Institute’s healthcare economics work and Center for United States Health System Reform. He has worked widely across the US and international healthcare systems to improve regulatory policy, economic performance, labor productivity, clinical outcomes, and patient experience.Bob received undergraduate degrees from the University of Washington and a medical degree from George Washington University. He completed a research fellowship with the Howard Hughes Medical Institute and the National Institutes of Health, and went on to complete his internal medicine residency training at the Beth Israel Deaconess Medical Center and the Harvard Medical School.

## Contacts

5 contacts available for Bob Kocher: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/bob-kocher?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 8 | 47% |
| Wellness | 3 | 18% |
| Medical | 2 | 12% |
| Employee Benefits | 2 | 12% |
| Information Technology | 2 | 12% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 5 | 29% |
| Series B | 4 | 24% |
| Series A | 3 | 18% |
| Series F | 1 | 6% |
| Funding Round | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Accompany Health | Accompany Health provides comprehensive in-home care to patients who live in sometimes underserved regions. Accompany Health offers primary care services such as chronic illness management and treatment of new symptoms. They also assist in the organization and coordination of care. There will be no more waiting rooms or lines for another form.Accompany Health cultivates long-term connections with the people they serve so that they know, without a doubt, that the team is there for them at all hours of the day and night, year after year. | $56M | Series A | Jan 30, 2024 |  |
| SmithRx | SmithRx is a pharmacy benefits partner built on a modern technology platform that creates new levels of flexibility, efficiency, and customer satisfaction. It’s a new path forward that aligns incentives and harnesses data analytics to deliver an exceptional pharmacy benefit product.A San Francisco-based technology company, SmithRx was founded in2016 to create a cost-competitive PBM that offers clients a proven pass-through model, a single technology platform, concierge-level service, and strong drug cost, rebate, and service level guarantees. The in-house team brings together experience from healthcare companies including Anthem, Collective Health, and Castlight Health, as well as a broader set of technology leaders including Facebook, LinkedIn, Glassdoor, and Docker. Front-line clinicians guide plan execution and member support.Named after a smith, a craftsman, or someone who is precise about their trade. SmithRx embodies these characteristics and brings precision to the pharmacy benefits industry by leveraging technology and data to forge the product of the future. | $60M | Series C | Jan 23, 2024 |  |
| Aledade | Aledade is a primary care physician platform to provide everything the doctors to create and run an Accountable Care Organization. Aledade partners with independent, primary care physicians to provide everything the doctors need to create and run an Accountable Care Organization (ACO) from business and practice transformation services to upfrontcapital and a cutting-edge technology platform. The company's customized solutions and continuous on-the-ground support of our physician partners will help doctors in all types of communities across America preserve their autonomy, deliver better care to their patients, reduce overall costs, and keep independent physician practices flourishing.Adelade was founded in 2014 and is headquartered in Bethesda, Maryland, United States. | $260M | Series F | Jun 21, 2023 |  |
| SmithRx | SmithRx is a pharmacy benefits partner built on a modern technology platform that creates new levels of flexibility, efficiency, and customer satisfaction. It’s a new path forward that aligns incentives and harnesses data analytics to deliver an exceptional pharmacy benefit product.A San Francisco-based technology company, SmithRx was founded in2016 to create a cost-competitive PBM that offers clients a proven pass-through model, a single technology platform, concierge-level service, and strong drug cost, rebate, and service level guarantees. The in-house team brings together experience from healthcare companies including Anthem, Collective Health, and Castlight Health, as well as a broader set of technology leaders including Facebook, LinkedIn, Glassdoor, and Docker. Front-line clinicians guide plan execution and member support.Named after a smith, a craftsman, or someone who is precise about their trade. SmithRx embodies these characteristics and brings precision to the pharmacy benefits industry by leveraging technology and data to forge the product of the future. | $27.2M | Series B | Mar 10, 2022 |  |
| Accompany Health | Accompany Health provides comprehensive in-home care to patients who live in sometimes underserved regions. Accompany Health offers primary care services such as chronic illness management and treatment of new symptoms. They also assist in the organization and coordination of care. There will be no more waiting rooms or lines for another form.Accompany Health cultivates long-term connections with the people they serve so that they know, without a doubt, that the team is there for them at all hours of the day and night, year after year. |  | Seed | Jan 01, 2022 |  |
| Stride Health | Stride Health is a provider of an insurance recommendation platform designed to offer health insurance services. Everyone deserves a smart way to protect your health – and your wallet – without breaking a sweat. That’s why we do the tricky calculus for you. In minutes we’ll enroll you in your most cost-effective health plan, minimize your taxes andmaximize your take-home pay as an independent worker or part-time employee. If that wasn’t enough, our personal advisors will navigate the details for you whenever you need us! | $47M | Series C | Oct 26, 2021 |  |
| Sitka | Sitka is a customizable video software platform that connects primary care providers to the virtual specialty provider network.By upskilling primary care providers, collapsing the care cycle, and enabling patient inclusion, Sitka is transforming specialty care in the US. Founded by healthcare experts in medicine, technology, policy, and product,Sitka’s mission is to foster informed, effective and trusted care delivery for all patients by every provider. The company is backed by investors including Venrock, Optum Ventures, First Round, Rock Health, Homebrew, Lifeforce Capital, and Box Group.It was established in San Francisco, California in 2018 by Kelsey Mellard, Shaun Lindsay, and Sohrab Gollogly. | $14M | Series A | Jan 19, 2021 |  |
| Lyra Health | Lyra helps companies improve access to effective, high-quality mental health care for their employees.Lyra's matching technology and innovative digital platform connect members to a curated network of top therapists and coaches, which results in 3x more people receiving care and 7x better outcomes than traditional plans and EAPs. Members canfind the right personalized care, match with the right provider for their needs, and feel motivated and supported throughout the entire treatment journey. | $75M | Series C | Mar 11, 2020 |  |
| Virta Health | Virta develops treatments to reversing type 2 diabetes without medications or surgery. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal, and 94% of insulin users reduced or eliminated usage altogether. Results extend beyond diabetes reversal to other areas of metabolic and cardiovascular health, withsustained improvements in blood pressure, inflammation, liver function, and BMI. Delivered through Virta’s novel continuous remote care platform, the Virta Treatment provides unparalleled medical and behavioral support and is transforming the lives of people living with type 2 diabetes. Founded in 2014, the company is headquartered in San Francisco, California. | $93M | Series C | Jan 10, 2020 |  |
| Lyra Health | Lyra helps companies improve access to effective, high-quality mental health care for their employees.Lyra's matching technology and innovative digital platform connect members to a curated network of top therapists and coaches, which results in 3x more people receiving care and 7x better outcomes than traditional plans and EAPs. Members canfind the right personalized care, match with the right provider for their needs, and feel motivated and supported throughout the entire treatment journey. | $65M | Series B | May 07, 2018 |  |

10 of 17 investments shown.

## Co-investors
- [IVP](https://shizune.co/investors/profile/institutional-venture-partners) — VC Fund, 5 deals together
- [Lightspeed Venture Partners](https://shizune.co/investors/profile/lightspeed-venture-partners) — VC Fund, 4 deals together
- [Tenaya Capital](https://shizune.co/investors/profile/tenaya-capital) — VC Fund, 4 deals together
- [Caffeinated Capital](https://shizune.co/investors/profile/caffeinated-capital) — VC Fund, 3 deals together
- [Glynn Capital Management](https://shizune.co/investors/profile/glynn-capital-management) — VC Fund, 3 deals together
- [Greylock](https://shizune.co/investors/profile/greylock) — VC Fund, 3 deals together

## About Stanford University

VC Fund · Stanford, United States

Stanford University is a teaching and research university that focuses on graduate programs in law, medicine, education, and business. Few colleges can match the breadth, excellence, and prestige of Stanford’s academics, both at the undergraduate and graduate levels. The university is organized into seven schools: Business, Earth Sciences,Education, Engineering, Humanities and Sciences, Law, and Medicine Student life at Stanford is quite active, due in part to the 11,000+ students living on campus. Art is a strong presence at Stanford, fostered by Stanford Lively Arts, the Cantor Center for Visual Arts, and numerous student clubs and organizations. Stanford also features extensive athletic programs, including more than 35 varsity sports and about 20 clubs sports. In order to maintain its high standards, Stanford University has extremely selective admissions. The university admits undergraduates based on a combination of academic achievement, intellectual curiosity, and personal experience. Graduate admissions criteria and application procedures vary based on the program of study. Undergraduates at Stanford have access to a variety of financial aid opportunities, including institutional scholarships, grants from the government, and student employment. Graduate students can receive financial aid through fellowships and grants, but funding is typically not available for master’s students.

5 contacts available at Stanford University.

| Name | Title | Profile |
| --- | --- | --- |
| Audrey Maclean | Consulting Associate Professor, School of Eng. | https://shizune.co/investors/profile/audrey-maclean |
| Badr Al-Rumaih | Graduate Research Assistant, Stanford Wave Physics Lab | https://shizune.co/investors/profile/badr-al-rumaih |
| Carolyn Bertozzi | Professor of chemistry | https://shizune.co/investors/profile/carolyn-bertozzi |
| Christopher Field | Perry L. McCarty Director, Stanford Woods Institute for the Environment | https://shizune.co/investors/profile/christopher-field-eb2e |
| Chuck Eesley | Associate Professor | https://shizune.co/investors/profile/chuck-eesley |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Bob Kocher invest in?

Bob Kocher invests primarily in Health Care, Wellness and Medical startups, most often at Series C and Series B stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Bob Kocher?

Public channels for Bob Kocher include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Bob Kocher last invest?

The most recent investment recorded for Bob Kocher closed in Jan 2024. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co